Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C H Polman

Showing results (261-270 of 290) with videos related to

Pageof 29
Sort By:
Journal of Neurology|October 22, 2010
BG-12 reduces evolution of new enhancing lesions to T1-hypointense lesions in patients with multiple sclerosisD G MacManus, D H Miller, L Kappos, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 31, 2010
Lesional magnetization transfer ratio: a feasible outcome for remyelinating treatment trials in multiple sclerosisI J van den Elskamp, D L Knol, H Vrenken, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 7, 2002
Two-year follow-up study of primary and transitional progressive multiple sclerosisG T Ingle, V L Stevenson, D H Miller, et al.
Annals of Neurology|November 30, 1999
Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights into substrates of disabilityJ H van Waesberghe, W Kamphorst, C J De Groot, et al.
Neurology|December 15, 2004
Value of health-related quality of life to predict disability course in multiple sclerosisM A J Visschedijk, B M J Uitdehaag, M Klein, et al.
Neurology|August 19, 2011
Interferon β-1b-neutralizing antibodies 5 years after clinically isolated syndromeH-P Hartung, M S Freedman, C H Polman, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 6, 2011
Relevance of IL7R genotype and mRNA expression in Dutch patients with multiple sclerosisM H Sombekke, L F van der Voort, J J Kragt, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 21, 2011
Predictive nature of IgM anti-α-glucose serum biomarker for relapse activity and EDSS progression in CIS patients: a BENEFIT study analysisM S Freedman, C Metzig, L Kappos, et al.
Brain : a Journal of Neurology|July 29, 2005
A longitudinal study of cognition in primary progressive multiple sclerosisS J Camp, V L Stevenson, A J Thompson, et al.
AJNR. American Journal of Neuroradiology|August 1, 1997
Single-dose gadolinium with magnetization transfer versus triple-dose gadolinium in the MR detection of multiple sclerosis lesionsJ H van Waesberghe, J A Castelijns, W Roser, et al.
Pageof 29

Showing results (261-270 of 290) with videos related to

Sort By:
Pageof 29
Journal of Neurology|October 22, 2010
BG-12 reduces evolution of new enhancing lesions to T1-hypointense lesions in patients with multiple sclerosisD G MacManus, D H Miller, L Kappos, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 31, 2010
Lesional magnetization transfer ratio: a feasible outcome for remyelinating treatment trials in multiple sclerosisI J van den Elskamp, D L Knol, H Vrenken, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 7, 2002
Two-year follow-up study of primary and transitional progressive multiple sclerosisG T Ingle, V L Stevenson, D H Miller, et al.
Annals of Neurology|November 30, 1999
Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights into substrates of disabilityJ H van Waesberghe, W Kamphorst, C J De Groot, et al.
Neurology|December 15, 2004
Value of health-related quality of life to predict disability course in multiple sclerosisM A J Visschedijk, B M J Uitdehaag, M Klein, et al.
Neurology|August 19, 2011
Interferon β-1b-neutralizing antibodies 5 years after clinically isolated syndromeH-P Hartung, M S Freedman, C H Polman, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 6, 2011
Relevance of IL7R genotype and mRNA expression in Dutch patients with multiple sclerosisM H Sombekke, L F van der Voort, J J Kragt, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 21, 2011
Predictive nature of IgM anti-α-glucose serum biomarker for relapse activity and EDSS progression in CIS patients: a BENEFIT study analysisM S Freedman, C Metzig, L Kappos, et al.
Brain : a Journal of Neurology|July 29, 2005
A longitudinal study of cognition in primary progressive multiple sclerosisS J Camp, V L Stevenson, A J Thompson, et al.
AJNR. American Journal of Neuroradiology|August 1, 1997
Single-dose gadolinium with magnetization transfer versus triple-dose gadolinium in the MR detection of multiple sclerosis lesionsJ H van Waesberghe, J A Castelijns, W Roser, et al.
Pageof 29